We are seeing patients in-person and through Video Visits. Learn more about how we’re keeping you safe and please review our updated visitor policy. Please also consider supporting Weill Cornell Medicine’s efforts to support our front-line workers.
Sandra and Edward Meyer Cancer Center

Warning message

The subscription service is currently unavailable. Please try again later.

You are here

News

Early stage kidney cancer treatment

Thursday, August 24, 2017

David M. Nanus, M.D., medical oncologist, Weill Cornell Medicine/NewYork-Presbyterian Hospital, spoke to OncLive about treatment for patients with early-stage kidney cancer. Therapies that are showing progress in the advanced setting, such as immunotherapy, may have a place in early-stage cancer, says Nanus.

In another interviewDr. Nanus discussed cytoreductive nephrectomy for patients with renal cell carcinoma (RCC).

There have been a number of retrospective analyses comparing patients who have had a cytoreductive nephrectomy versus those who did not, explains Nanus. It was clear that patients who had a cytoreductive nephrectomy experienced a higher response.

According to Nanus, if a person can undergo a cytoreductive nephrectomy they should have one as the procedure is associated with improved survival.